109137 ⎘
Structure or type of the nucleic acid; Type of nucleic acid catalytic nucleic acids, e.g. ribozymes Hairpin
SERS BIOSENSOR BASED ON CRISPR/CAS13A SYSTEM AND APPLICATION THEREOF
#2STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS
#3Treating herpesvirus-mediated intestinal dysfunction for prevention of age-related neurodegeneration
#4SCARLESS GENOME EDITING THROUGH TWO-STEP HOMOLOGY DIRECTED REPAIR
#5AMBIENT TEMPERATURE NUCLEIC ACID AMPLIFICATION AND DETECTION
#6Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)
#7METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE
#8SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY
#9INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#10MOLECULAR PROGRAMMING TOOLS
#11Use of Trinucleotide Repeat RNAs To Treat Cancer
#12COMPOSITIONS AND METHODS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
#13GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#14Compositions and Methods for Suppression of Flowering in Sugarcane and Energycane
#15Multiplex Amplification Detection Assay II
#16METHODS OF MAKING CIRCULAR RNA
#17COMPOSITIONS AND METHODS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN HUMAN ANGELMAN SYNDROME
#18ANTI-PTEN RNA INTERFERENCE OLIGONUCLEOTIDES AND USES THEREOF
#19Treatment Of Myeloid Cell Dysfunction With Membrane Spanning 4-Domains A6A (MS4A6A) Inhibitors
#20COMPOSITIONS AND METHODS FOR PREPARING CAPPED CIRCULAR RNA MOLECULES
#21HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#22MATERIALS AND METHODS FOR CONTROLLING GENE EDITING
#23RIBOZYME-ASSISTED CIRCULAR RNAS AND COMPOSITIONS AND METHODS OF USE THEREOF
#24m6A mRNA MODIFICATION IN CANCER TREATMENT
#25ENHANCED PRODUCTION OF SQUALENE IN PLANT SYSTEMS
#26TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES
#27COMPOSITIONS AND METHODS FOR PRODUCTION OF CIRCULAR NUCLEIC ACID MOLECULES
#28METHOD FOR MEASURING SOMATIC DNA MUTATION AND DNA DAMAGE PROFILES AND A DIAGNOSTIC KIT SUITABLE THEREFORE
#29RNAi TARGETING PPP2R5D MISSENSE MUTATIONS FOR TREATMENT OF JORDAN’S SYNDROME
#30RNAi TARGETING HNRNPH2 MISSENSE MUTATIONS FOR TREATMENT OF BAIN SYNDROME
#31UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS
#32EXPLOITING IL33 SECRETION AS A THERAPEUTIC TARGET IN CANCER
#33SGF29 AS A TARGET FOR HOX/MYC DRIVEN CANCERS
#34METHODS FOR ALTERING GENE EXPRESSION FOR GENETIC DISORDERS
#35Gene-regulating compositions and methods for improved immunotherapy
#36Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
#37LINEAR DNA WITH ENHANCED RESISTANCE AGAINST EXONUCLEASES AND METHODS FOR THE PRODUCTION THEREOF
#38MULTIGENE CONSTRUCTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER COMPLEMENT DYSREGULATION-RELATED CONDITIONS
#39GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION
#40DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM
#41Compositions and Methods for Gene Editing in T Cells Using CRISPR/Cpf1
#42LIPID NANOPARTICLE SPHERICAL NUCLEIC ACIDS
#43MODIFIED DOUBLE-STRANDED DONOR TEMPLATES
#44COMPOSITIONS COMPRISING SASP MODULATORS AND SENESCENCE ATTENUATORS AND USES THEREOF FOR MODULATING CELLULAR SENESCENCE
#45Method of Treatment for Auditory Dysfunction
#46Therapeutic Editing
#47Use Of Citicoline In Regulating Respiratory Chain Function Related Protein Level And Preparing Drug For Preventing And Treating Respiratory Chain Dysfunction
#48COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE
#49CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION
#50HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
#51Synthetic Near-Threshold Translational Repressors
#52RNAi-NANOPARTICLE CONJUGATE, COMPOSITION, AND METHOD OF SYNTHESIS THEREOF
#53NUCLEIC ACIDS SIMULTANEOUSLY INHIBITING EXPRESSION OF C-MET GENE AND PD-L1 GENE
#54Targeted extracellular vesicles for delivery of therapeutics
#55Driving Axon Regeneration by Activating STAT1 Signaling and cGAS-STING Pathway
#56INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE
#57RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF
#58METHODS AND POLYNUCLEOTIDES FOR AMPLIFYING A TARGET POLYNUCLEOTIDE
#59Delivery of therapeutics in vivo via a CRISPR-based cascade system
#60PRE-IMMUNIZATION AND IMMUNOTHERAPY
#61TOXIC RNAi ACTIVE SEED SEQUENCES FOR KILLING CANCER CELLS
#62Linear DNA With Enhanced Resistance Against Exonucleases and Methods for the Production Thereof
#63COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES
#64SUPPRESSING HIPPO SIGNALING IN THE STEM CELL NICHE PROMOTES SKELETAL MUSCLE REGENERATION
#65RECONFIGURABLE DNA NANO-TWEEZER
#66RNA Vectors with Hairpin-like Inserts
#67MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN
#68METHODS FOR REGULATING BLOOD-CENTRAL NERVOUS SYSTEM (BLOOD-CNS) BARRIER AND USES THEREOF
#69Use of non-coding RNA SNHG17 as biomarker and therapeutic target
#70METHODS FOR IMPROVING CRISPR/CAS-MEDIATED GENOME-EDITING
#71SCARLESS GENOME EDITING THROUGH TWO-STEP HOMOLOGY DIRECTED REPAIR
#72Gene-regulating compositions and methods for improved immunotherapy
#73THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#74shRNA TARGETING UBE3A-ATS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN ANGELMAN SYNDROME
#75shRNA TARGETING SNORD115 LOCATIONS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN ANGELMAN SYNDROME
#76WATER-BASED HYPOTONIC LYSIS METHOD FOR ADENO-ASSOCIATED VIRUS PURIFICATION
#77Targeting enhancer RNAs for the treatment of primary brain tumors
#78MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRO-RNA TO ALTER THEIR PROPERTIES AND THE COMPOSITIONS OF THEIR PRODUCTS
#79REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE
#80METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION
#81KITS, METHODS, POLYPEPTIDES, SYSTEMS, AND NON-TRANSITORY, MACHINE-READABLE STORAGE MEDIA FOR DETECTING A NUCLEIC ACID
#82SYNTHESIS METHOD OF TARGETED DRUG nCoVshRNA 2ACE2
#83ELECTROCHEMICAL DETECTION NANOSTRUCTURE, SYSTEMS AND USES THEREOF
#84NUCLEIC ACID MOLECULE TARGETING MITF GENE AND USE THEREOF
#85GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#86T CELL, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF
#87DELIVERY OF GENE EXPRESSION MODULATING AGENTS FOR THERAPY AGAINST CANCER AND VIRAL INFECTION
#88Methods and Systems of Molecular Recording by Crispr-Cas System
#89Nucleoporins as drug targets for anti-proliferative therapeutics
#90RESPONSIVE, CATALYTIC NUCLEIC NANOSTRUCTURES
#91METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS
#92METHODS FOR THE TREATMENT OF VIRAL RESPIRATORY INFECTIONS
#93COMPOSITION AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#94OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING
#95Methods and Compositions for Directed Genome Editing
#96Compositions and methods for treating pathologic calcification
#97TARGETING TRANSFER RNA FOR THE SUPPRESSION OF NONSENSE MUTATIONS IN MESSENGER RNA
#98COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#99Therapeutic editing
#100TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS
#101ORAL DELIVERY OF OLIGONUCLEOTIDES
#102Nucleus-encoded male sterility through mutation in cytochrome P450 oxidase
#103Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#104Molecular programming tools
#105CAR NKTs Expressing Artificial Micro RNA-Embedded shRNA for Downregulation of MHC Class I & II Expression
#106ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME
#107Enhanced immune cells using dual shRNA and composition including the same
#108Gene-regulating compositions and methods for improved immunotherapy
#109INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER
#110Use of Thermostable RNA Polymerases to Produce RNAs Having Reduced Immunogenicity
#111GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#112Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
#113Oligonucleotide interference treatments of prostate cancer
#114Gene-regulating compositions and methods for improved immunotherapy
#115Inhibitors of microRNA 451a for Treatment of Endometriosis
#116p16INK4a INHIBITOR FOR PREVENTING OR TREATING HUNTINGTON'S DISEASE
#117MODULATORS OF TELOMERE DISEASE
#118Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
#119Gene-regulating compositions and methods for improved immunotherapy
#120SYSTEM FOR GENOME EDITING
#121HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID
#122ONE-STEP GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY VIA GENE REPLACEMENT AND ANTI-INFLAMMATION
#123CORE MASTER REGULATORS OF GLIOBLASTOMA STEM CELLS
#124METHODS FOR TREATING MACROPHAGE-MEDIATED DISEASES, AND METHODS OF IDENTIFYING AGENTS USEFUL THEREFORE
#125Multiplex amplification detection assay II
#126IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#127CRISPR-cas9 SYSTEM AND USES THEREOF
#128Engineered immunostimulatory bacterial strains and uses thereof
#129REDUCING CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
#130Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence
#131METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING
#132MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES
#133OLIGOMERIC NUCLEIC ACID MOLECULE AND APPLICATION THEREOF
#134RNA nanoparticles and method of use thereof
#135COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY
#136Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#137METHODS OF TREATING SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC DISORDERS
#138Ubiquitin-specific peptidase 24 inhibitor, medicinal composition including the same and method of delaying or reversing multidrug resistance in cancers using the same
#139TRANS-ACTIVATED FUNCTIONAL RNA BY STRAND DISPLACEMENT AND USES THEREOF
#140Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
#141Gene-regulating compositions and methods for improved immunotherapy
#142Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#143METHODS OF INHIBITING PROLIFERATIVE CELLS
#144Method of delivering genes and drugs to a posterior segment of an eye
#145METHOD FOR PREVENTING OR TREATING CANCER USING SYT11 INHIBITOR
#146Therapeutic and diagnostic methods relating to cancer stem cells
#147Compositions and methods for treating beta-hemoglobinopathies
#148Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome
#149MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF
#150HIV pre-immunization and immunotherapy
#151AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
#152Method of producing hairpin single-stranded RNA molecules
#153Methods and compositions for directed genome editing
#154NATURAL GUIDE ARCHITECTURES AND METHODS OF MAKING AND USING THE SAME
#155Methods and compositions for directed genome editing
#156COMPOSITIONS AND METHODS FOR REDUCING SPLICEOPATHY AND TREATING RNA DOMINANCE DISORDERS
#157Compositions and methods for treating RSV-infections
#158Methods and systems of molecular recording by CRISPR-Cas system
#159REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE
#160Compositions and methods for treatment of dominant retinitis pigmentosa
#161COMPOSITIONS AND METHODS OF USE OF ARC CAPSIDS
#162METHODS AND AGENTS FOR ENHANCING T CELL THERAPIES
#163TREATING HERPESVIRUS-MEDIATED INTESTINAL DYSFUNCTION FOR PREVENTION OF AGE-RELATED NEURODEGENERATION
#164Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)
#165Tumor immunotherapy target and application thereof
#166Targeting P18 for mTOR-related disorders
#167Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
#168Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor
#169Use of trinucleotide repeat RNAs to treat cancer
#170Synthetic near-threshold translational repressors
#171METHODS AND COMPOSITIONS FOR INHIBITING NECROPTOSIS IN NEUROVASCULAR AND/OR NEURODEGENERATIVE DISEASES OR DISORDERS
#172Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity
#173Mammalian cells for producing a secreted protein
#174Modified double-stranded donor templates
#175Trans-activated functional RNA by strand displacement and uses thereof
#176Compositions and methods for modulating left-right differentiation factor (LEFTY) and bone morphogenic factor (BMP)
#177Gene-regulating compositions and methods for improved immunotherapy
#178Enhanced immune cells using dual shRNA and composition including the same
#179INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#180Efficient sequencing of dsDNA with extremely low level of errors
#181Materials and methods for controlling gene editing
#182METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE
#183THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#184METHOD OF TREATING TYPE II DIABETES AND OBESITY AND METHOD OF SCREENING A MEDICAMENT FOR THE SAME
#185Viral complex comprising shRNA and anti-EpCAM antibody and uses thereof
#186Novel method of treating dystonia
#187Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#188CRISPR/Cas system and method for genome editing and modulating transcription
#189COMPOSITIONS AND METHODS FOR EDITING RNA
#190COMPOSITIONS AND METHODS FOR REGULATION OF GENE EXPRESSION WITH, AND DETECTION OF, FOLINIC ACID AND FOLATES
#191Multiplex amplification detection assay II
#192ISOLATION OF EXTRACELLULAR VESICLES (EVS) FROM RED BLOOD CELLS FOR GENE THERAPY
#193Methods and compositions for improving exercise endurance, performance, or tolerance
#194Scarless genome editing through two-step homology directed repair
#195Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
#196Gene-regulating compositions and methods for improved immunotherapy
#197Mammalian cells for producing a secreted protein
#198Modulating RNA Interactions with Polycomb Repressive Complex 1 (PRC1)
#199Nucleoporins as drug targets for anti-proliferative therapeutics
#200Reconfigurable DNA nano-tweezer
#201METHODS FOR ALTERING GENE EXPRESSION FOR GENETIC DISORDERS
#202HIV pre-immunization and immunotherapy
#203COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#204METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE
#205Engineered immunostimulatory bacterial strains and uses thereof
#206Adaptor for sequencing DNA at ultratrace level and use thereof
#207Method of delivering genes and drugs to a posterior segment of an eye
#208COMPOSITIONS COMPRISING SASP MODULATORS AND SENESCENCE ATTENUATORS AND USES THEREOF FOR MODULATING CELLULAR SENESCENCE
#209Compositions and methods for gene editing in T cells using CRISPR/Cpf1
#210Methods and polynucleotides for amplifying a target polynucleotide
#211Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression
#212Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor
#213Methods for sub-typing and treating cancer
#214Electrochemical detection nanostructure, systems, and uses thereof
#215INHIBITION OF NEDDYLATION USING GLYCYL-tRNA SYNTHETASE INHIBITORS
#216RNAi therapy for treatment and/or prevention of glaucoma
#217Exosome delivery system
#218COMPLEX FOR DRUG DELIVERY AND STABILIZATION AND PREPARATION METHOD THEREOF
#219Consequences of a defective switch in cutaneous squamous cell carcinoma
#220ENHANCED HETATOPOIETIC STEM CELL TRANSPLANTATION
#221SEMAPHORIN 3D AND PLEXIN D1 AS THERAPEUTIC TARGETS FOR PANCREATIC CANCER TREATMENT
#222Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#223Visceral adipose tissue macrophage-targeted gene/carrier complex for preventing or treating obesity-induced type II diabetes
#224Gene-regulating compositions and methods for improved immunotherapy
#225GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#226Compositions and methods for promoting the mineralization of biological tissue
#227CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#228Inhibition of KMT2D for the treatment of cancer
#229METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION
#230AAV delivery of shRNA for treatment of pancreatic cancer
#231COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES
#232Modulation of TJP1 expression to regulate regeneration of heart cells
#233EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof
#234Neuronal enhancers
#235Engineered guide RNA and uses thereof
#236SPATIOTEMPORAL REGULATORS
#237Methods and compositions for selecting siRNA of improved functionality
#238Methods of treating a wound using epigenetic regulation
#239COMPOSITIONS AND METHODS FOR TARGETING FRUCTOSE ENZYMES AND TRANSPORTERS FOR THE TREATMENT OF CANCER
#240Method of determining target nucleic acid
#241GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#242Modulators of telomere disease
#243ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in alzheimer's disease
#244Anabolic Enhancers for Ameliorating Neurodegeneration
#245Genetically-modified cells and method for producing same
#246HIV pre-immunization and immunotherapy
#247Nucleus-encoded male sterility through mutation in cytochrome P450 oxidase
#248Synthetic near-threshold translational repressors
#249Multiplex amplification detection assay II
#250Treatment of HER2-Dependent Cancers by SORL1 Inhibition
#251Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)
#252Allele-specific gene suppression
#253METHOD FOR MITIGATING METASTASIS
#254METHODS OF TREATING DISEASES ASSOCIATED WITH ILC3 CELLS
#255Methods involving Menain screening for inhibitors of cancer invasion and metastasis
#256COMPOSITION FOR SOLUBILIZING TARGET PROTEIN AND USE THEREOF
#257Molecular programming tools
#258Compositions and methods for treating beta-hemoglobinopathies
#259AAV vectors for treatment of dominant retinitis pigmentosa
#260POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS
#261Methods and compositions using RNA interference for inhibition of KRAS
#262Targeting pleiotrophin signaling to limit high-grade glioma invasion
#263Isolation of extracellular vesicles (EVs) from red blood cells for gene therapy
#264Gene/carrier complex for preventing or treating inflammatory diseases
#265RNA cleavage-induced transcript stabilizer and uses thereof
#266METHOD OF MODULATING SURVIVAL AND STEMNESS OF CANCER STEM CELLS BY MDA-9/SYNTENIN (SDCBP)
#267Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents
#268Expression system for eukaryotic organisms
#269DNA aptamer binding to cancer cell
#270ANIMAL MODELS FOR BRAIN INFLAMMATION AND WHITE MATTER DEGENERATION
#271Argonaute protein-double stranded RNA complexes and uses related thereto
#272Methods and compositions for integration defective lentiviral vectors
#273Toxic RNAi active seed sequences for killing cancer cells
#274Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#275COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER FIBROSIS
#276Methods for improving CRISPR/Cas-mediated genome-editing
#277Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#278METHODS AND COMPOSITIONS FOR PROMOTING HAIR GROWTH
#279PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE BRAIN DISEASE AND SCREENING METHOD FOR THE SAME
#280METHODS FOR TREATING AND/OR PREVENTING A TUMOR GROWTH, INVASION AND/OR METASTASIS
#281Use of trinucleotide repeat RNAs to treat cancer
#282METHODS AND COMPOSITIONS FOR ENHANCING GENE EDITING
#283SYSTEMS AND METHODS FOR SELECTION OF GRNA TARGETING STRANDS FOR CAS9 LOCALIZATION
#284Nanoparticle conjugates and uses thereof
#285Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates
#286Monitoring and analysis of nucleic acid hybridization state and amplification using L-DNA
#287ALKB -FACILITATED RNA METHYLATION SEQUENCING (ARM-SEQ)
#288Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#289INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE
#290Therapy for malignant disease
#291Method and kit for use in inhiiting tumor progression, predicting or determining tumor progression state in VGF expressing cancers
#292RNA nanoparticles and method of use thereof
#293Cleavable hairpin primers
#294Composition for treating cancer associated with HPV infection
#295Method for controlling obesity using minimally invasive means
#296Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
#297Method for controlling obesity using minimally invasive means
#298Method for controlling obesity using minimally invasive means
#299Targeting peptides for directing adeno-associated viruses (AAVs)
#300Algal mutants with increased lipid productivity